A novel coronavirus, designated as 2019-nCoV, hit the central Chinese city of Wuhan in late
December 2019, and subsequently spread rapidly to all provinces of China and multiple …

Viral bronchiolitis is the most common cause of admission to hospital for infants in high-
income countries. Respiratory syncytial virus accounts for 60–80% of bronchiolitis …

The 2019 novel coronavirus (2019-nCoV) outbreak is a major challenge for clinicians. The
clinical course of patients remains to be fully characterised, little data are available that …

This guideline is a revision of the clinical practice guideline,“Diagnosis and Management of
Bronchiolitis,” published by the American Academy of Pediatrics in 2006. The guideline …

Viral bronchiolitis is a common clinical syndrome affecting infants and young children.
Concern about its associated morbidity and cost has led to a large body of research that has …

In global terms, respiratory viral infection is a major cause of morbidity and mortality. Infancy,
in particular, is a time of increased disease susceptibility and severity. Early-life viral …

Background Previous systematic reviews have not shown clear benefit of glucocorticoids for
acute viral bronchiolitis, but their use remains considerable. Recent large trials add …

Viral bronchiolitis is a leading cause of acute illness and hospitalization of young children.
Research into the variation in treatment and outcomes for bronchiolitis across different …

While the world is facing an unprecedented pandemic with COVID‐19, patients with chronic
diseases need special attention and if warranted adaptation of their regular treatment plan …

Aim Bronchiolitis is the most common lower respiratory tract disorder in infants aged less
than 12 months, and research has demonstrated that there is substantial variation in practice …